Literature DB >> 29683510

Availability of an ADAMTS13 assay with rapid turnaround time may avoid interhospital transfer in patients with thrombotic microangiopathy.

Christian P Nixon1, Tracey A Cheves2, Joseph D Sweeney2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29683510     DOI: 10.1111/trf.14546

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  2 in total

1.  Economic impact of a rapid, on-demand ADAMTS-13 activity assay for the diagnosis of thrombotic thrombocytopenic purpura.

Authors:  Alicia White; Rosie Martin; Keven Sew; Amanda Stucke; Rob Cook
Journal:  Res Pract Thromb Haemost       Date:  2022-05-20

2.  Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study.

Authors:  Jan Stratmann; Josephine-Nana Ward; Wolfgang Miesbach
Journal:  J Thromb Thrombolysis       Date:  2020-10       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.